Share Twitter LinkedIn Facebook Email William Oh, MD, Chief of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai explains the differences between the ENZAMET and TITAN studies. Advertisement
Joe Biden Prostate Cancer Timeline: When Did It Begin? Experts Weigh In Acute Myelogenous Leukemia 4 Mins Read
MOASC Awards $25,000 Research Grant from AVEO Oncology to Dr. Peter Zang, MD of City of Hope 2025 Cary Presant, MD Investigator Award Prostate Cancer Treatment 4 Mins Read